Pharma Podcast PharmaSource Podcast The PharmaSource podcast shares exclusive insights and best practices, challenges and commercial opportunities from Biopharma outsourcing professionals.Subscribe wherever you get your podcasts: Apple, Youtube or Spotify. Latest Episodes Combination Product Manufacturing: GLP-1 Hype, Talent Shortages, and the CDMO Shift ▶️Play Novartis on What Great CDMO Partnerships Actually Look Like ▶️Play How Eramol’s Purpose-Built Sterile Facility Targets Less Than 1% Material Loss for Biotech Clients ▶️Play Delpharm CEO: Every Day Lost in Clinical Manufacturing Is a Day of Peak Sales Gone Forever ▶️Play Why Pharma’s Direct-to-Consumer Shift Is Moving Faster Than Infrastructure Can Handle ▶️Play How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform ▶️Play Digital Twins in Claude: How BioPharma Can Build Forecast and Supply Models ▶️Play Hybrid Synthesis is Redefining Peptide Manufacturing ▶️Play The Case for Strategic CDMO Partnerships Over Multi-Sourcing ▶️Play CDMO Consolidation “Inevitable” Without Business Model Shift, Warns Cell Therapy CEO ▶️Play How Trump’s Most-Favored-Nation Policy Is Forcing Europe’s Pharma Industry to Reconsider Its Pricing Strategy ▶️Play How Europe’s Critical Medicines Act Could Reshape Generic Drug Supply Chains ▶️Play Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy ▶️Play How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO ▶️Play U.S. Vaccine Policy Shifts Create a “Chilling” Effect on Global Manufacturing and Innovation ▶️Play Why Pharmaceutical Contract Negotiations Are Flawed and How to Fix Them ▶️Play How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai ▶️Play SGS CDMO Solutions to Launch Digital Transparency Platform ▶️Play 2026 US Pharma Outsourcing: Gil Roth on FDA Cuts, Pricing Pressures and CDMO Strategy ▶️Play Radiopharmaceutical Winners Must Compete on Service Excellence – Not Clinical Data ▶️Play Simtra BioPharma Solutions CEO Franco Negron on Building Supply Chain Resilience Through Geographic Redundancy ▶️Play How Integrated Drug Development and Manufacturing Creates Speed Advantage in Contract Pharma ▶️Play How Charles River Helps Sponsors Accelerate Drug Development Through Strategic Testing ▶️Play ADC Manufacturing Demand Outpaces Capacity in US Market ▶️Play Breaking the Death Spiral: How to Rescue Failing CDMO Relationships Before It’s Too Late ▶️Play After a Decade Building Poland’s Pharma Leader, CEO Says Europe Needs a New Supply Model ▶️Play CordenPharma CEO on Scaling GLP-1 Production and Competing in Complex Modalities ▶️Play What BioPlan’s 22-Year Data Reveals About the Future of Biopharmaceutical Outsourcing ▶️Play How Piramal Pharma Built a $1 Billion CDMO by Solving Client Problems, Not Selling Services ▶️Play The End of Global Pharma Supply Chains: How Regionalization Will Impact Industry Profitability ▶️Play
How Eramol’s Purpose-Built Sterile Facility Targets Less Than 1% Material Loss for Biotech Clients ▶️Play
How the BMC Achieves Clinical-to-Commercial Quality Continuity Across Its Biologics CDMO Platform ▶️Play
How Trump’s Most-Favored-Nation Policy Is Forcing Europe’s Pharma Industry to Reconsider Its Pricing Strategy ▶️Play
Reshoring America’s Critical Medicines: How the API Innovation Center Turns Idle Capacity Into a Drug Security Strategy ▶️Play
How Radiopharmaceutical Supply Chains Win the Race Against Radioactive Decay: Insights from Daniel Rossetto, ARTBIO ▶️Play
How Biotechs Can De-Risk External Manufacturing, Navigate Geopolitical Challenges, and Plan for Capacity Constraints – Dr. Reza Oliyai ▶️Play
Simtra BioPharma Solutions CEO Franco Negron on Building Supply Chain Resilience Through Geographic Redundancy ▶️Play
The End of Global Pharma Supply Chains: How Regionalization Will Impact Industry Profitability ▶️Play
